glp-1/gip dual agonist lilly Triple Agonism Based Therapies for Obesity GLP1 agonists: current and future

[DOI] [PubMed] [Google Scholar] 10.Franzosa E.A., Sirota-Madi A., Avila-Pacheco J., Fornelos N., Haiser H.J., Reinker S., Vatanen T., Hall A.B., Mallick H., McIver L.J., et al

Regan Campbell, Executive Director, PEO SUB, Department of the Navy, DoD Small Business Transition Program, presentation to NRC, June 25, 2013

Corneal confocal microscopy: recent progress in the evaluation of diabetic neuropathy

doi: 10.1210/en.2012-1422 89 YilmazBTerekeciHSandalSKelestimurF

Figure 2 ) and lower insulin (tAUC 30911 13770 vs 59580 26382 pmol/L x min, p=0.005) excursions were observed in the T2D relapse subgroup ( vs remission), but no significant differences in C-peptide excursion profiles were observed between subgroups ( Table 2 )

It acts as an antioxidant, protecting the skin from damage caused by free radicals